Impaired communication between immune cells leads to cognitive impairment in female Alzheimer’s patients

FHS
July 3, 2024
11:47 am

Lead author Neta Rosenzweig, PhD, of the Ann Romney Center for Neurological Diseases, and senior author Oleg Butovsky, PhD, of the Ann Romney Center and Gene Lay Institute of Immunology and Inflammation, share key messages from their paper “Sex-Dependent APOE4 Neutrophil-Microglia Interactions Drive Cognitive Impairment in Alzheimer’s Disease” published in Nature Medicine.

Neoadjuvant Chemoradiation Plus Immunotherapy Boosts Responses in Esophageal Cancer

SAN FRANCISCO — Neoadjuvant chemoradiotherapy with or without the investigational PD-1 inhibitor sintilimab significantly increased pathological complete response (pCR) rates compared with neoadjuvant chemotherapy plus

January 25, 2025

FDA cracks down on off-label drug use messaging – Pharmaceutical Technology

The FDA acknowledged the usefulness of off-label uses for approved drugs for diseases with no approved therapies. Credit: klevo via Shutterstock The US Food and

October 24, 2023

Machine learning speeds up virtual drug screening by 10-fold

Boosting virtual screening with machine learning allowed for a 10-fold time reduction in the processing of 1.56 billion drug-like molecules. Researchers from the University of

September 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.